Carevision

What Carevision does

Carevision is an AI-powered preventive healthcare platform that delivers 60-second contactless cardiometabolic wellness screening via a standard camera (smartphone, tablet, laptop, or kiosk). Its core technology uses remote photoplethysmography (rPPG) computer vision combined with deep learning models trained on over 12 million patient records to detect subtle facial skin color variations tied to blood flow, producing a "Digital Health Persona" — a structured output of 30+ physiological parameters and 15+ cardiometabolic disease risk indicators. The platform operates under FDA General Wellness guidelines and is explicitly positioned as a wellness screening tool rather than a diagnostic medical device, with all clinical decisions retained by licensed healthcare providers.

Carevision sells primarily to enterprise customers across six segments: hospitals and clinics, insurance companies, pharmacy chains, wellness apps, teleconsultation platforms, and diagnostic laboratories. Named deployments include King Faisal Specialist Hospital, Al Borg Diagnostics, the Saudi Ministry of Hajj AI Innovation Lab, and Al Zubair Group, with distribution leverage through partnerships with Microsoft, STC, Mobily, SEDCO, and Dal Digital. Geographically the company is concentrated in Saudi Arabia and the wider GCC, with corporate headquarters in Florida, US, and is led by founder and CEO Dr. Amani Amin, whose team draws affiliations from Stanford Medicine, Imperial College London, University of Cambridge, and NHS clinical advisors.

The business model is multi-pronged: enterprise SaaS platform licensing (quote-based, typically annual or multi-year), SDK and API licensing for embedded integration (mobile, web, HL7/FHIR EMR/HIS), white-label/OEM deployments under partner brands, and per-screening economics of $50-$200 for implementing partners such as pharmacies and hospitals. The company is privately held with 1-10 employees, founded per firmographics in 2024, with no disclosed revenue or traditional VC funding rounds in the source material.

Name

Carevision

Legal name

Carevision

Website

https://carevisionai.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Carevision is an AI-powered preventive healthcare platform that delivers 60-second contactless cardiometabolic wellness screening via facial scan using rPPG technology. It serves hospitals, insurers, pharmacies, and digital health platforms primarily across the GCC, with US headquarters in Florida.

Ownership category

akta.pro rank

Product category

Digital Health Screening Software

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLALAFAA

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)

Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

SECONDARYHLACAPAI

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)

Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

SECONDARYHLALABAF

Chronic Care & Remote Patient Monitoring (RPM) Platforms

Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)

SECONDARYHLACAPAB

Connected Medical Devices & Wearables (Sensors, Patches, Implantables)

Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

SECONDARYHLAHACAL

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

Keywords

• AI health screening
• Contactless biometrics
• Preventive wellness platform
• Cardiometabolic risk assessment
• Digital health SDK

Headquarters

HQ city

Florida

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Enterprise SaaS Platform Licensing: B2B SaaS licensing model for healthcare organizations, insurance companies, pharmacy chains, and wellness platforms. Pricing appears quote-based with customization for organizational scale and integration requirements.
2. SDK Integration Services: Revenue from embedding SDK into partner platforms (mobile apps, wellness apps, teleconsultation platforms). Integration services and ongoing API access licensing.
3. Screening Services Revenue: Per-screening revenue stream for healthcare providers. Blog content references $50-$200 per screening revenue opportunity for pharmacy and hospital implementations.
4. White-Label/OEM Licensing: Full white-label option allowing partners to deploy Carevision AI under their own brand, generating licensing and branding fees.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels4 records

Core offering

Carevision develops and licenses an AI-powered contactless health-screening platform that uses remote photoplethysmography (rPPG) and computer vision to extract cardiac, vascular, and metabolic biomarkers from a standard camera feed in roughly 60 seconds, without any wearable hardware. The platform is delivered as Enterprise SaaS, Mobile (iOS/Android) and JavaScript SDKs, Tablet and Enterprise Kiosks, a RESTful API, and White-Label configurations for clinical and consumer health partners.

Product overview

Carevision offers a unified AI-powered wellness screening platform centered on its 60-second contactless cardiometabolic scanning technology. The core platform transforms any camera into a risk scanner, generating a comprehensive Digital Health Persona with 30+ physiological parameters. The portfolio includes deployment-ready modules: Mobile App SDK (iOS/Android), JavaScript SDK for web platforms, Tablet Kiosk and Enterprise Kiosk for physical deployments, a RESTful API with HL7/FHIR support for EMR/HIS integration, and a White-Label option for branded deployments. Together, these products enable healthcare providers, insurers, pharmacies, and wellness platforms to embed or deploy AI-powered screening across any channel.

Differentiator

Problem solved

Functional benefit

Products and services

• Carevision AI Health Screening Platform (Enterprise SaaS) Licensed enterprise SaaS platform that performs AI-driven, 60-second contactless cardiometabolic screening using rPPG and computer vision, intended for hospitals, clinics, insurance providers, pharmacy chains, wellness apps, teleconsultation platforms and diagnostic labs.
• Mobile App SDK (iOS / Android) Native iOS and Android SDK that lets third-party app developers embed Carevision's contactless cardiometabolic screening directly inside their own health and wellness applications.
• JavaScript SDK (Web) JavaScript SDK that enables web-based telehealth, wellness, and digital health platforms to run Carevision's contactless cardiometabolic screening directly in the browser.
• RESTful API HL7/FHIR-compliant RESTful API that lets enterprise clinical and health-IT systems call Carevision's contactless screening models and consume the resulting cardiac, vascular and metabolic biomarker data.
• Tablet Kiosk Tablet-based self-service kiosk that runs Carevision's contactless cardiometabolic screening, designed for retail pharmacies, clinics and other point-of-care locations.
• Enterprise Kiosk Larger-format Enterprise Kiosk for high-throughput contactless cardiometabolic screening at hospitals, insurer sites, pharmacies and other enterprise partner locations.
• White-Label / OEM Solution White-label and OEM configuration of the Carevision screening platform that lets partners rebrand and resell the contactless screening experience under their own corporate identity.

Quantifiable outcome

• 94% accuracy in disease detection (often surpassing human radiologists)
• +9 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability8 records

Feature9 records

Partnerships

Four partnerships are on record, tiered core and major.

• MicrosoftcoreTechnology or IntegrationTechnology partner providing cloud infrastructure and platform support for Carevision's AI-powered health screening platform. Microsoft logo appears in partner section of website.
• STC (Saudi Telecom Company)coreGTM or Marketing PartnerMajor telecommunications partner in Saudi Arabia enabling Carevision deployment across STC's enterprise customer base and consumer channels in the GCC region.
• MobilymajorGTM or Marketing PartnerTelecommunications partner enabling mobile and digital health integrations in the Saudi Arabian market. Mobily logo appears in partners section.
• SEDCOmajorStrategic or Co-development PartnerStrategic business partner in the GCC region, appearing in Carevision's partner ecosystem supporting regional market expansion.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Current Health: RPM platform acquired by Best Buy Health offering wearable-based remote monitoring with hospital-at-home focus; competes for similar health-system and insurer budgets in chronic care management.
• Vivify Health: Established RPM and virtual care platform for health systems and payers; broader incumbent with deeper clinical workflow integration but reliant on wearable/connected device form factors.
• EarlySense: Established contact-free patient monitoring provider for hospitals and post-acute care; broader incumbent in continuous monitoring with a different sensor modality but overlapping clinical buyers.
• Philips Remote Patient Monitoring: Broad incumbent offering enterprise RPM, telehealth, and population health solutions to hospitals and insurers; competes for the same preventive-care budget line items as Carevision.

Direct peers

• Nuralogix: Direct competitor with its Anura platform performing contactless health measurements (heart rate, blood pressure, stress) from a face scan, sold to insurers and digital health apps.
• FaceHeart Corporation: Direct competitor using remote photoplethysmography from facial video to extract vital signs, with comparable SDK-based deployment into telemedicine and RPM use cases.
• Preventicus: Direct competitor offering contactless smartphone-based vital-sign screening (heart rhythm, blood pressure) via apps and SDKs for pharma, insurers, and telehealth partners.
• Binah.ai: Direct competitor offering AI-based contactless vital-sign monitoring from facial video using rPPG and computer vision, targeting insurers, telehealth, and wellness platforms globally.

Emerging players

• Biobeat: AI-powered RPM platform offering continuous remote patient monitoring with connected sensors and predictive analytics — overlapping in cardiometabolic risk monitoring but using wearable form factor.
• iHealth Labs: Connected health device maker offering home-monitoring hardware and apps for vitals; adjacent peer that competes for pharmacy and consumer wellness channel mindshare.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/in/amani-abulaban-89796124

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Carevision